Dr. Fred Cohen, M.D., D.Phil is a Co-Founder and Chairman of Monograph Capital Partners. He is also a Co-Founder and Senior Managing Director at Vida Ventures.  

Prior to Monograph, Dr. Cohen was a Partner and founder of TPG Biotechnology, a life science focused investment effort from 2001-2016.  

From 1980 through 2014, Dr. Cohen was at UCSF where he held various clinical responsibilities as a research scientist, an internist for hospitalized patients, a consulting endocrinologist, and as the Chief of the Division of Endocrinology and Metabolism.  

Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his M.D. from Stanford and his postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF. Dr. Cohen has been a member of the National Academy of Medicine since 2004 and the American Academy of Arts and Sciences since 2008.